Home NDC 42291-210 Chlordiazepoxide Hydrochloride
Product NDC 42291-210
11-digit product format 422910210
Labeler code 42291
Product ID 42291-210_91c16c72-786d-a266-e053-2995a90a0cca
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Chlordiazepoxide Hydrochloride
Dosage form CAPSULE, GELATIN COATED
Route ORAL
Labeler AvKARE, Inc.
Application ANDA085461
Marketing category ANDA
Marketing start 2011-03-14
Marketing end 0000-00-00
Substance CHLORDIAZEPOXIDE HYDROCHLORIDE
Active strength 5 mg/1
Pharmacologic classes Benzodiazepine [EPC],Benzodiazepines [CS]
DEA schedule CIV
NDC exclude flag No
Listing certified through 2020-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 24 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 42291-210-90 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 42291-210-90 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 42291-210-90 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 42291-210-90 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 42291-210-90 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 42291-210-90 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 42291-210-90 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 42291-210-90 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 42291-210-90 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 42291-210-90 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 42291-210-90 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 42291-210-90 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A085461-001 LIBRIUM CHLORDIAZEPOXIDE HYDROCHLORIDE 5MG CAPSULE / ORAL AB RLD, Approved before 1982
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A085461-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB Approved before 1982 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB Approved before 1982 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB Approved before 1982 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB Approved before 1982 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB Approved before 1982 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB Approved before 1982 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB Approved before 1982 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB Approved before 1982 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB Approved before 1982 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A085461-001 LIBRIUM 5MG CAPSULE / ORAL AB RLD, Approved before 1982 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT MFM6K1XWDK CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE, GELATIN COATED [AVKARE, INC.] 4 CHLORDIAZEPOXIDE ACTIVE MOIETY 6RZ6XEZ3CR CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE, GELATIN COATED [AVKARE, INC.] 4 D&C YELLOW NO. 10 INACTIVE INGREDIENT 35SW5USQ3G CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE, GELATIN COATED [AVKARE, INC.] 4 FD&C BLUE NO. 1 INACTIVE INGREDIENT H3R47K3TBD CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE, GELATIN COATED [AVKARE, INC.] 4 FD&C GREEN NO. 3 INACTIVE INGREDIENT 3P3ONR6O1S CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE, GELATIN COATED [AVKARE, INC.] 4 FD&C RED NO. 40 INACTIVE INGREDIENT WZB9127XOA CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE, GELATIN COATED [AVKARE, INC.] 4 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE, GELATIN COATED [AVKARE, INC.] 4 GELATIN INACTIVE INGREDIENT 2G86QN327L CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE, GELATIN COATED [AVKARE, INC.] 4 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE, GELATIN COATED [AVKARE, INC.] 4 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE, GELATIN COATED [AVKARE, INC.] 4 POTASSIUM SORBATE INACTIVE INGREDIENT 1VPU26JZZ4 CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE, GELATIN COATED [AVKARE, INC.] 4 PROPYLPARABEN INACTIVE INGREDIENT Z8IX2SC1OH CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE, GELATIN COATED [AVKARE, INC.] 4 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE, GELATIN COATED [AVKARE, INC.] 4 TALC INACTIVE INGREDIENT 7SEV7J4R1U CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE, GELATIN COATED [AVKARE, INC.] 4 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP CHLORDIAZEPOXIDE HYDROCHLORIDE CAPSULE, GELATIN COATED [AVKARE, INC.] 4
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.